GlaxoSmithKline (GSK) Africa Open Laboratory Research Grant

GlaxoSmithKline (GSK) Africa Open Laboratory Research Grant 2024

GlaxoSmithKline (GSK) Africa Open Laboratory Research Grant 2024 is ongoing for applicants that meet the grant requirements.

GlaxoSmithKline (GSK) is a science-led global healthcare company with a special purpose to improve the quality of human life by helping people do more, feel better, live longer. Every day, we help improve the health of millions of people around the world by discovering, developing and manufacturing innovative medicines, vaccines and consumer healthcare products.

We are building a stronger purpose and performance culture underpinned by our values and expectations – so that together we can deliver extraordinary impact for patients and consumers and make GSK a brilliant place to work.

Applications are invited for:

Title: Africa Open Laboratory Research Grant


  • We want to change the trajectory of high-burden infectious diseases that disproportionately affect undeserved people in lower income countries.
  • Infectious diseases (IDs) such as malaria, tuberculosis (TB) and enteric diseases are among the leading causes of death globally, killing almost 9 million people each year. These diseases, which are often preventable and treatable, disproportionately affect sub-Sahara African (SSA) populations, causing significant morbidity and mortality.
  • Research is critical for the development and implementation of effective measures to meet the global health challenges of eliminating IDs.
  • Having previously funded 20 projects through the Africa NCD Open Lab, we are now calling for research proposals focussed on funding high-quality infectious disease research that has the potential to deliver significant health impact and develop future research leaders, with up to £75,000 available per award. Along with the award we offer mentoring, scientific and technical support while you conduct your innovative research project. 


The Applicant

You must meet all of the following criteria:

  • The principal investigator must be an African scientist in the early stages of their research and academic career, defined as: a basic biomedical scientist, clinically qualified investigator, or public health researcher, who has not previously competed successfully as principal investigator for a major research grant (£100,000), and who is no more than five years from their highest postgraduate qualification (career breaks and time out of academic research will be taken into consideration).
  • The minimum formal qualification required is a graduate degree. Most applicants will be expected to have a MSc, PhD or an MD. Applicants can hold a lecturer appointment, a junior fellowship, or be in another research staff position.
  • Must demonstrate a track record and ongoing commitment to health-related research and the skills and experience required to carry out the proposed work. Evidence of research output, including publications in peer reviewed journals, conference publications, presentations at scientific conferences, input into clinical guidelines or policy documents is required.
  • Employed by a research or academic institution in SSA. Additionally, applications are strongly encouraged from historically underrepresented population groups and institutions.
  • A national of a sub-Saharan African country and based in an institution in SSA.

The Research Project
Your project must meet the following criteria:

  • Research proposal of relevance to disease understanding in the following disease areas:
    • Malaria
    • Tuberculosis
    • Enteric infections
    • Respiratory infections
    • Neglected Tropical Diseases
    • Emerging infectious diseases of particular relevance for Africa
    • Other bacterial infections
    • Antimicrobial resistance (AMR) linked to these infectious diseases
  • Research must address one or more of:
    • Infectious disease epidemiology
    • Pathophysiology
    • Aetiology
    • The emergence of antimicrobial resistance linked to these infectious diseases, antibiotic stewardship
    • Mechanisms for improving access to and optimising use of medicines and vaccines in SSA
    • Prevention and treatment of primary disease
    • The significant gaps in knowledge about the diversity and causes of disease
    • Disease presentation and variations in clinical features
    • Responses to medicines and vaccines
  • Will generate significant data to strengthen further funding proposals that could lead to additional grant funding from other organisations and/or research collaborations in the longer term.
  • Proposals must demonstrate significant potential to scale up into further research. Proposals can include laboratory-based molecular analysis of field or clinical samples, but projects focused solely on studies in vitro, drug or vaccine discovery or using animal models will not be considered.

The Award
What’s included?

  • Up to £75,000 available per award to cover a project for up to 36 months.
  • The award will offer funding to cover the costs of an appropriate research project including costs for equipment, field work and data collection, consumables, and research assistance.
  • There will be opportunities to undertake training activities relevant to achieving the aims of the project or research career development, including short courses and training visits to relevant research institutions, to be agreed in consultation with GSK.
  • In addition to financial support, GSK will provide scientific support throughout the duration of the award term. The level of interaction will be determined through the application process and will be tailored to the individual needs of the project. GSK will explore links with scientists from academic and research groups in Africa and globally to provide mentorship to successful applicants.
  • Funding is not provided for degree/fellowship tuition fees.

Method of Application

Interested and qualified candidates should:
Click here to apply

Application Deadline  17th February, 2023.

Application Instruction
Applications for research grants will be subject to a 2-stage review process. Only those successful at the concept stage will be invited to submit a full application. Recommendations for award funding will be made based on scientific merit.

  • Please go to the GSK Supported Studies website, you will need to register to access the Preliminary Concept Application Form.
  • Complete the “Preliminary Concept Application Form” and submit it along with your CV (Please use the CV Template provided in the application form).
  • Read the full “Conditions for Applicants” before submitting your application.

The selection process:

  • Completed proposals will be assessed by a scientific panel, including the scientific advisory board of African infectious disease experts and academics from other institutions.
  • Those assessed as competitive will be invited to submit a full application.
  • Please note that we will not provide written feedback for unsuccessful applications at the preliminary application stage.
  • Reviewers will typically assess:
    • The eligibility of the applicant
    • The scientific merit of the proposed project
    • The significance and potential impact of the research
    • The potential for scaling up the research
    • The potential impact of the project on your career development.

Click here for more information about the Research Program